HSCI retweeted
Please Retweet! - Postdoctoral Research Fellow and Research Assistant positions available in our group at @BostonChildrens @harvardmed @harvardstemcell to work on @NIH funded projects on #Bioengineering @vascularbiology #RegenerativeMedicine #organoids
meleromartinlab.com/opportun…
HSCI retweeted
📢Paola Arlotta @ArlottaLab, @harvardstemcell, will deliver the next instalment in the Gurdon Institute Seminar Series.
📅 30 May ⏰ 2 pm (BST) 📍online 👉 bit.ly/3MQxlwi
HSCI retweeted
Researchers have discovered a new mechanism that influences #melanoma development, a finding that could have wide implications for patients across a variety of cancers. @leonard_zon @InscoLab @BCHStemCell news.harvard.edu/gazette/sto…
HSCI retweeted
Congrats to Megan Insco on our new paper in Science on CDK13 mutations in melanoma. This shows tumor suppression by RNA surveillance. Megan recently started her lab at Dana-Farber Cancer Institute. Thanks Robert Fisher for the Perspective on our paper. science.org/doi/epdf/10.1126…
We are speaking with Dr. Zhigang He, Prof. of #Ophthalmology & principal member of the @harvardstemcell Institute, about axon regeneration to repair optic nerve & spinal cord injuries. Thank you for sharing this beautiful work, Dr. He!
#SpinalCordInjury
kirbyneuro.org/ZhigangHe/
Dr. Vikram Khurana joined us today via Zoom to talk about alpha-synuclein and modeling the pathology of protein inclusions in cell types of the central nervous system. Thank you for a great seminar about this impressive body of work!
@harvardstemcell
HSCI retweeted
Please Retweet! - Research Assistant position available in our group at @BostonChildrens @harvardmed @harvardstemcell to work on @NIH funded projects on #Bioengineering, @vascularbiology, #Regenerative #Medicine.
More information at meleromartinlab.com/opportun…
HSCI retweeted
Cell therapy engineered to eliminate established tumors, train immune system to prevent cancer recurrence
@khalidshahs @koksiongchen
hms.harvard.edu/news/vaccine…
@harvardstemcell @BWHNeurosurgery
@harvardmed @NIH @ScienceTM
HSCI retweeted
Killing cancer with cancer @Harvard @khalidshahs @BrighamWomens @harvardstemcell
news.harvard.edu/gazette/sto…
HSCI retweeted
We're pleased to welcome @JessicaLehoczky from @harvardstemcell as the distinguished speaker at the @USCStemCell seminar on Tuesday 10/25 at 11am. @KeckSchool_USC calendar.usc.edu/event/usc_s…
HSCI retweeted
Our featured article is: tRNA dysregulation and disease go.nature.com/3NEtIqP #Review by @eorellanav, Elisabeth Siegal & Richard I. Gregory @BostonChildrens @Harvardmed @harvardstemcell @Harvard
HSCI retweeted
Can we 3D-print replacement kidney tissue? Trestle Biosciences has launched to commercialize a suite of kidney regenerative medicine technologies developed at @hseas @wyssinstitute & @BrighamWomens hvrd.me/mH3w50I1yht
HSCI retweeted
Alkem has licensed a novel technology developed at @hseas and @wyssinstitute that may help meet the need for effective treatment of diabetic neuropathy, foot ulcers, peripheral arterial disease, and other injuries caused by vascular disease hvrd.me/ITom50HS8Wo
HSCI retweeted
“Meet the Scientist: Douglas Melton” on vimeo.com/442134935/9f56d698… special thanks to @JDRF and @TheMeltonLab team! @HSCRB
“The promising results we’ve seen with #stemcell-derived islet cells could deliver a life-changing therapy for people who suffer from the relentless life-long burden of #Type1diabetes," said Dr. Douglas Melton, co-director of @harvardstemcell Institute.
Sheikh Mohamed bin Zayed, Crown Prince of Abu Dhabi, provides grant to Harvard Stem Cell Institute for diabetes research thenationalnews.com/uae/scie…
According to the @WHO about 422 million people worldwide have #diabetes, and 1.6 million deaths are directly attributed to diabetes each year.
We are excited to announce this collaboration with @harvardstemcell in search for a #type1diabetes cure. bit.ly/3LkExO4
HSCI retweeted
#RESEARCHERS: In a recent @SciReports paper, our scientists investigate with @harvardstemcell and @MassGeneralNews collaborators the molecular cause of #NASH 👉 Learn more: rdcu.be/cxwhP
HSCI retweeted
FINAL WEEK: to catch our session "How Visionary Collaborations Foster Investment, Discovery & Cures" @MD_Stem_Cell @CIRMnews @CCRM_ca @harvardstemcell.
Register now to access over 130 summits & courses through 2021 @WSCSummit #WSCS21. Access ends 9/16! bit.ly/3AdEY6O
HSCI retweeted
#KevinEggan at @harvardstemcell, #CliffordWoolf, and QurAlis CEO @RoetKasper published a paper in
@CellReports strengthening our hypothesis that QurAlis’ QRL-101 has the potential to treat hyperexcitability induced neurodegeneration in #ALS patients. bit.ly/3v8VGRx

























